Navigation Links
Palatin Technologies to Present at BOCEMb, Noble Financial Capital Markets' Eighth Annual Equity Conference
Date:1/16/2012

CRANBURY, N.J., Jan. 16, 2012 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced that Dr. Carl Spana, President and Chief Executive Officer will present at BOCEMb, Noble Financial Capital Markets' Eighth Annual Equity Conference.  The presentation is scheduled for Tuesday, January 17th, at 9:30 a.m. Eastern Time.  BOCEMb will be held at the Hard Rock Hotel in Hollywood, Florida.

A live audio and high-definition video webcast of Palatin's presentation and a copy of the presentation materials will be available through Noble Financial websites www.noblefcm.com or www.BOCEM2012.com.  To ensure timely access, it is recommended to register at least 10 minutes prior to the start of the presentation.  You will require a Microsoft SilverLight viewer (a free download from the presentation link) to participate. A live audio broadcast only will also be available on the "Investors" section of Palatin's website at www.palatin.com.  The live audio broadcast will be available through January 24, 2012.

About Palatin Technologies

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at http://www.palatin.com

About Noble Financial

Noble Financial Capital Markets was established in 1984 and is an equity research driven, full-service, investment banking boutique focused on small-cap, emerging growth companies. The company has offices in New York, Boston, New Jersey, Philadelphia, Los Angles, St Louis, and Boca Raton. In addition to non-deal road shows and sector-specific conferences throughout the year, Noble Financial hosts its large format annual equity conference in January in South Florida featuring 120 – 150 presenting companies from across North America and total attendance of close to 600. For more information: www.noblefcm.com.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
2. Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies, Inc.
3. Palatin Technologies, Inc. March 31, 2011 Quarter Results; Teleconference and Webcast to be Held on May 16, 2011
4. FDA Clears Palatin Technologies IND Filing to Commence Clinical Studies for Asthma
5. Palatin Technologies, Inc. Closes $23 Million Public Offering
6. Palatin Technologies Listing Compliance Plan Accepted by NYSE Amex
7. Palatin Technologies Receives Non-Compliance Letter from NYSE Amex
8. Palatin Technologies to Present at 9th Annual BIO Investor Forum
9. Palatin Technologies to Present at Rodman & Renshaw Annual Global Investment Conference
10. Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
11. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... FRANCISCO , March 23, 2017  The ... interoperable system to identify and track prescription drugs as ... , in response to requirements from US FDA ... removal of potentially dangerous medicines. Blockchain ... with cryptographic identity chips and blockchain technology and recently ...
(Date:3/23/2017)... York , March 23, 2017 ... a consolidated vendor landscape with the top five ... market in 2015. These companies are Stryker Sustainability ... Hygia Health Services, Inc., and VANGUARD AG. Despite ... medical devices market is witnessing the prevalence of ...
(Date:3/23/2017)... CAMBRIDGE, Mass. , March 23, 2017 ... the enrollment of its first patient in a Phase ... an antibody-directed nanotherapeutic (ADN) that encapsulates a novel taxane ... suggest is overexpressed in 50-100% of many major tumor ... cancers. "The initiation of this study is ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... A recent report from the ... teacher preparation programs. The NCTQ report suggests, based on a review of GPA and ... improve teacher quality in the U.S. It argues that this higher bar should be ...
(Date:3/23/2017)... ... , ... The IoT (Internet of Things) is revolutionizing the way the world ... businesses and individual consumers alike. Laboratories can maximize their profit margin by increasing ... $4 trillion to $11 trillion dollars by the year 2025. McKinsey expects the IoT ...
(Date:3/23/2017)... ... March 23, 2017 , ... Benefits ... an innovative mobile app and centralized benefits dashboard solving one of the top ... from multiple locations. For the first time, employees can access up-to-date information and ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... businesses of the greater Fort Collins area, has unveiled a collaboration with nonprofit ... involvement program. Donations to this worthy cause may now be made at ...
(Date:3/23/2017)... ... March 23, 2017 , ... ChenMed, a privately owned ... of the strategic executive team expansion needed to further optimize growth and performance. ... team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. “George Wheeler and ...
Breaking Medicine News(10 mins):